Panel Discussion: Comparative Market Analysis of Wet AMD Treatments: Trends & Opportunities
Time: 3:45 pm
day: Day Two
Details:
- Evaluate the current landscape of anti-VEGF therapies across Wet AMD, highlighting differences in treatment efficacy, patient demographics, and injection frequencies
- Analyze the economic impact and market penetration of newer treatments like faricimab and biosimilars, considering their uptake and performance in realworld settings compared to traditional therapies
- Identify emerging trends and unmet needs in each treatment area, focusing on the potential for innovative therapies to address gaps in efficacy, durability, and patient compliance
